X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (36277) 36277
Newsletter (5104) 5104
Book Review (5096) 5096
Publication (1611) 1611
Newspaper Article (379) 379
Conference Proceeding (353) 353
Magazine Article (324) 324
Book Chapter (192) 192
Dissertation (87) 87
Trade Publication Article (68) 68
Transcript (51) 51
Web Resource (13) 13
Book / eBook (12) 12
Reference (10) 10
Paper (6) 6
Government Document (4) 4
Presentation (4) 4
Data Set (3) 3
Streaming Video (2) 2
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
warfarin (27620) 27620
index medicus (25277) 25277
humans (24480) 24480
male (12870) 12870
female (12377) 12377
aged (9379) 9379
warfarin - therapeutic use (8692) 8692
anticoagulants - therapeutic use (8514) 8514
middle aged (8461) 8461
atrial fibrillation (7594) 7594
anticoagulants (7567) 7567
stroke (6128) 6128
anticoagulants - adverse effects (5573) 5573
risk factors (5536) 5536
anticoagulants - administration & dosage (5475) 5475
adult (5358) 5358
warfarin - adverse effects (5208) 5208
abridged index medicus (5111) 5111
warfarin - administration & dosage (4972) 4972
cardiac & cardiovascular systems (4841) 4841
research (4312) 4312
anticoagulation (4116) 4116
aged, 80 and over (4041) 4041
prevention (3947) 3947
pharmacology & pharmacy (3859) 3859
medicine, general & internal (3799) 3799
peripheral vascular disease (3781) 3781
atrial fibrillation - drug therapy (3671) 3671
therapy (3564) 3564
hematology (3563) 3563
treatment outcome (3544) 3544
international normalized ratio (3378) 3378
risk (3313) 3313
thromboembolism (3173) 3173
care and treatment (3126) 3126
administration, oral (3056) 3056
dabigatran (3028) 3028
aspirin (2925) 2925
management (2885) 2885
atrial fibrillation - complications (2875) 2875
stroke - prevention & control (2857) 2857
hemorrhage - chemically induced (2748) 2748
drug therapy (2713) 2713
thrombosis (2684) 2684
analysis (2680) 2680
retrospective studies (2617) 2617
atrial-fibrillation (2576) 2576
medical research (2450) 2450
animals (2412) 2412
medicine, experimental (2228) 2228
drug interactions (2141) 2141
surgery (2121) 2121
dosage and administration (2108) 2108
reports (2108) 2108
time factors (2103) 2103
hemorrhage (2050) 2050
warfarin - pharmacology (2042) 2042
rivaroxaban (2036) 2036
health aspects (2012) 2012
thromboembolism - prevention & control (1813) 1813
stroke - etiology (1768) 1768
venous thromboembolism (1762) 1762
mortality (1738) 1738
medicine & public health (1718) 1718
stroke prevention (1706) 1706
follow-up studies (1642) 1642
prospective studies (1628) 1628
patients (1597) 1597
complications and side effects (1517) 1517
prothrombin time (1513) 1513
cardiac arrhythmia (1512) 1512
bleeding (1510) 1510
antithrombotic therapy (1500) 1500
drugs (1496) 1496
aspirin - therapeutic use (1490) 1490
risk assessment (1435) 1435
heparin - therapeutic use (1413) 1413
cardiology (1386) 1386
dose-response relationship, drug (1383) 1383
apixaban (1381) 1381
pharmacogenetics (1360) 1360
safety (1358) 1358
usage (1324) 1324
thrombin (1314) 1314
clinical neurology (1301) 1301
heparin (1290) 1290
oral anticoagulants (1271) 1271
oral anticoagulation (1257) 1257
adolescent (1251) 1251
blood coagulation - drug effects (1237) 1237
complications (1232) 1232
risk-factors (1226) 1226
anticoagulants - pharmacology (1184) 1184
universities and colleges (1153) 1153
vitamin k - antagonists & inhibitors (1144) 1144
drug therapy, combination (1135) 1135
pharmacokinetics (1131) 1131
platelet aggregation inhibitors - therapeutic use (1114) 1114
rats (1111) 1111
clinical trials (1092) 1092
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (39866) 39866
Japanese (505) 505
German (362) 362
French (361) 361
Spanish (343) 343
Russian (209) 209
Chinese (141) 141
Portuguese (105) 105
Czech (95) 95
Italian (91) 91
Swedish (85) 85
Turkish (73) 73
Norwegian (63) 63
Korean (51) 51
Polish (49) 49
Danish (33) 33
Hungarian (25) 25
Finnish (20) 20
Hebrew (18) 18
Slovak (13) 13
Dutch (9) 9
Croatian (6) 6
Persian (6) 6
Serbian (6) 6
Slovenian (5) 5
Bulgarian (4) 4
Afrikaans (3) 3
Romanian (3) 3
Ukrainian (2) 2
Arabic (1) 1
Bosnian (1) 1
Georgian (1) 1
Icelandic (1) 1
Lithuanian (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA, ISSN 0098-7484, 03/2018, Volume 319, Issue 12, p. 1278
Journal Article
Experimental Hematology, ISSN 0301-472X, 09/2017, Volume 53, pp. S60 - S60
Journal Article
2008, Revisado Agosto de 2008, AHRQ pub., Volume no. 08-0028-B
eBook
Ultrasound in Obstetrics & Gynecology, ISSN 0960-7692, 10/2013, Volume 42, Issue s1, pp. 150 - 151
Journal Article
Clinical Biochemistry, ISSN 0009-9120, 09/2012, Volume 45, Issue 13-14, p. 1119
Journal Article
La Revue de medecine interne, ISSN 0248-8663, 01/2015, Volume 36, Issue 1, p. 7
En cas de changement de molecule d'antivitamine K, la warfarine remplacant la fluindione ou inversement, se pose le probleme de la posologie du nouveau... 
Warfarin
Journal Article
Journal Article
Pharmacy Times, ISSN 0003-0627, 03/2013, Volume 79, Issue 3
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2011, Volume 365, Issue 10, pp. 883 - 891
In this trial, 14,264 patients with atrial fibrillation were randomly assigned to receive either rivaroxaban or warfarin. In a per-protocol, as-treated... 
NON-INFERIORITY | ENOXAPARIN | MEDICINE, GENERAL & INTERNAL | DABIGATRAN | STROKE PREVENTION | PHARMACOKINETICS | EFFICACY | ANTITHROMBOTIC THERAPY | PHARMACODYNAMICS | THROMBOPROPHYLAXIS | ANTICOAGULATION | Thiophenes - therapeutic use | Thiophenes - adverse effects | Humans | Middle Aged | Warfarin - adverse effects | Male | Thiophenes - administration & dosage | Warfarin - administration & dosage | Warfarin - therapeutic use | Rivaroxaban | Aged, 80 and over | Female | Stroke - epidemiology | Embolism - epidemiology | Morpholines - adverse effects | Morpholines - therapeutic use | Stroke - prevention & control | Embolism - prevention & control | Double-Blind Method | Administration, Oral | Atrial Fibrillation - drug therapy | Morpholines - administration & dosage | Atrial Fibrillation - complications | Anticoagulants - therapeutic use | Treatment Outcome | Anticoagulants - adverse effects | Intention to Treat Analysis | Aged | Hemorrhage - chemically induced | Stroke (Disease) | Warfarin | Atrial fibrillation | Patient outcomes | Dosage and administration | Drug therapy | Comparative analysis | Risk factors | Fees & charges | Cardiac arrhythmia | Stroke | Heart attacks | Research & development--R&D | Embolisms | Equity | Equity stake | Hemorrhage | Bleeding | Embolism | Studies | Prevention | Fibrillation | Motivation | Ischemia | Thromboembolism | Drug dosages | Pharmaceuticals | Index Medicus | Abridged Index Medicus | Anticoagulants | Morpholines | Life Sciences | Thiophenes | Atrial Fibrillation
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2015, Volume 373, Issue 9, pp. 823 - 833
Journal Article